Bartlett JG, Moon N, Chang TW, et al. Role of Clostridium difficile in antibiotic-associated pseudomembranous colitis. Gastroenterology 1978;75(5):778–782. DOI: 10.1016/0016-5085(78)90457-2.
Hopkins RJ, Wilson RB. Treatment of recurrent Clostridium difficile colitis: a narrative review. Gastroenterol Rep 2018;6(1):21–28. DOI: 10.1093/gastro/gox041.
Srikhanta YN, Hutton ML, Awad MM, et al. Cephamycins inhibit pathogen sporulation and effectively treat recurrent Clostridioides difficile infection. Nat Microbiol 2019;4(12):2237–2245. DOI: 10.1038/s41564-019-0519-1.
Lam SW, Neuner EA, Fraser TG, et al. Cost-effectiveness of three different strategies for the treatment of first recurrent Clostridium difficile infection diagnosed in a community setting. Infect Control Hosp Epidemiol 2018;39(8):924–930. DOI: 10.1017/ice.2018.139.